EYES - Second Sight Medical Products, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 594.19M
Enterprise Value 374.71M
Trailing P/E N/A
Forward P/E 1-2.91
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)14.66
Price/Book (mrq)4.45
Enterprise Value/Revenue 311.63
Enterprise Value/EBITDA 6-2.38

Trading Information

Stock Price History

Beta (3Y Monthly) 1.38
52-Week Change 3-50.32%
S&P500 52-Week Change 30.90%
52 Week High 31.9800
52 Week Low 30.6350
50-Day Moving Average 30.8181
200-Day Moving Average 30.8213

Share Statistics

Avg Vol (3 month) 3195.73k
Avg Vol (10 day) 3162.81k
Shares Outstanding 559.88M
Float 44.94M
% Held by Insiders 129.74%
% Held by Institutions 16.13%
Shares Short (Jul 31, 2019) 44.81M
Short Ratio (Jul 31, 2019) 440.7
Short % of Float (Jul 31, 2019) 411.59%
Short % of Shares Outstanding (Jul 31, 2019) 43.86%
Shares Short (prior month Jun 28, 2019) 45.02M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-494.78%

Management Effectiveness

Return on Assets (ttm)-88.01%
Return on Equity (ttm)-256.10%

Income Statement

Revenue (ttm)6.42M
Revenue Per Share (ttm)0.07
Quarterly Revenue Growth (yoy)-32.80%
Gross Profit (ttm)2.01M
EBITDA -31.37M
Net Income Avi to Common (ttm)-35.52M
Diluted EPS (ttm)-0.3910
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)25.16M
Total Cash Per Share (mrq)0.2
Total Debt (mrq)2.71M
Total Debt/Equity (mrq)12.77
Current Ratio (mrq)3.58
Book Value Per Share (mrq)0.17

Cash Flow Statement

Operating Cash Flow (ttm)-28.97M
Levered Free Cash Flow (ttm)-13.69M